Holen Sie sich die Stockscreener-App
1.85
39.10%
0.52
Handel nachbörslich:
1.84
-0.01
-0.54%
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
9.27%
17.10
|
18.84 | 19.10 | 20.79 | 21.61 |
| Nonoperating Income/Loss |
7.49%
2.064
|
2.231 | 2.654 | 2.779 | 2.877 |
| Income/Loss From Continuing Operations Before Tax |
9.51%
-15.03
|
-16.61 | -16.45 | -18.01 | -18.73 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
9.51%
-15.03
|
-16.61 | -16.45 | -18.01 | -18.73 |
|
Net Income/Loss
|
9.51%
-15.03
|
-16.61 | -16.45 | -18.01 | -18.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.05%
126.20
|
126.14 | 125.45 | 125.32 | 125.14 |
| Diluted Average Shares |
0.05%
126.20
|
126.14 | 125.45 | 125.32 | 125.14 |
| Basic Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.13 | -0.14 | -0.15 |
| Diluted Earnings Per Share |
7.69%
-0.12
|
-0.13 | -0.13 | -0.14 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):